Literature DB >> 1330167

Albumin inhibits platelet-activating factor (PAF)-induced responses in platelets and macrophages: implications for the biologically active form of PAF.

G Grigoriadis1, A G Stewart.   

Abstract

1. Platelet-activating factor (PAF) binds with high affinity to albumin leading Clay et al. (1990) to suggest that the active form of PAF is the albumin-PAF complex. 2. In the present study the proposal that albumin-bound, rather than monomeric PAF, is the active form of PAF at PAF receptors was critically evaluated by examining the effect of albumin on the potency of PAF in isolated platelets and macrophages. 3. Bovine serum albumin inhibited concentration-dependently PAF-induced responses in platelets and macrophages. The most probable explanation of this finding is that BSA reduced the concentration of free PAF. 4. Thus, we conclude that free PAF, rather than the albumin-PAF complex is the active form. Consequently, local concentrations of albumin will influence profoundly the potency of endogenously released PAF. Moreover, estimates of the affinity of PAF for PAF receptors made in buffers containing BSA, underestimate the true affinity of PAF for its receptors by approximately 3 orders of magnitude.

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1330167      PMCID: PMC1907628          DOI: 10.1111/j.1476-5381.1992.tb14465.x

Source DB:  PubMed          Journal:  Br J Pharmacol        ISSN: 0007-1188            Impact factor:   8.739


  14 in total

1.  Binding of platelet activating factor to albumin.

Authors:  K L Clay; C Johnson; P Henson
Journal:  Biochim Biophys Acta       Date:  1990-10-01

2.  1-O-hexadecyl-2-acetyl-sn-glycero-3-phospho (N,N,N trimethyl) hexanolamine: an analogue of platelet-activating factor with partial agonist activity.

Authors:  G Grigoriadis; A G Stewart
Journal:  Br J Pharmacol       Date:  1991-09       Impact factor: 8.739

Review 3.  Perspectives in platelet-activating factor research.

Authors:  P Braquet; L Touqui; T Y Shen; B B Vargaftig
Journal:  Pharmacol Rev       Date:  1987-06       Impact factor: 25.468

Review 4.  Fatty acid binding to plasma albumin.

Authors:  A A Spector
Journal:  J Lipid Res       Date:  1975-05       Impact factor: 5.922

5.  The effect of bovine serum albumin on the synthesis of prostaglandin and incorporation of [3H]acetate into platelet-activating factor.

Authors:  C Heinsohn; P Polgar; J Fishman; L Taylor
Journal:  Arch Biochem Biophys       Date:  1987-09       Impact factor: 4.013

6.  Characterization of receptors for platelet-activating factor on platelets, polymorphonuclear leukocytes and macrophages.

Authors:  A G Stewart; G J Dusting
Journal:  Br J Pharmacol       Date:  1988-08       Impact factor: 8.739

7.  Modulation of platelet-activating factor (PAF) synthesis and release from human polymorphonuclear leukocytes (PMN): role of extracellular albumin.

Authors:  J C Ludwig; C L Hoppens; L M McManus; G E Mott; R N Pinckard
Journal:  Arch Biochem Biophys       Date:  1985-09       Impact factor: 4.013

8.  Evidence for protein-catalyzed transfer of platelet activating factor by macrophage cytosol.

Authors:  J B Banks; R L Wykle; J T O'Flaherty; R H Lumb
Journal:  Biochim Biophys Acta       Date:  1988-07-01

Review 9.  Specific receptors of platelet-activating factor, receptor heterogeneity, and signal transduction mechanisms.

Authors:  S B Hwang
Journal:  J Lipid Mediat       Date:  1990 May-Jul

10.  Leukocyte-dependent histamine release from rabbit platelets. The role of IgE, basophils, and a platelet-activating factor.

Authors:  J Benveniste; P M Henson; C G Cochrane
Journal:  J Exp Med       Date:  1972-12-01       Impact factor: 14.307

View more
  11 in total

1.  Analysis of variation in L-365,260 competition curves in radioligand binding assays.

Authors:  E A Harper; S P Roberts; N P Shankley; J W Black
Journal:  Br J Pharmacol       Date:  1996-08       Impact factor: 8.739

Review 2.  Investigational therapies for ischemic stroke: neuroprotection and neurorecovery.

Authors:  Preeti Sahota; Sean I Savitz
Journal:  Neurotherapeutics       Date:  2011-07       Impact factor: 7.620

3.  Symptomatic intracranial hemorrhage in the ALIAS Multicenter Trial: relationship to endovascular thrombolytic therapy.

Authors:  Myron D Ginsberg; Michael D Hill
Journal:  Int J Stroke       Date:  2015-03-22       Impact factor: 5.266

Review 4.  Anesthetic management of patients with intracranial aneurysms.

Authors:  Alaa A Abd-Elsayed; Anthony S Wehby; Ehab Farag
Journal:  Ochsner J       Date:  2014

5.  Low Serum Albumin Predicts Severe Outcomes in COVID-19 Infection: A Single-Center Retrospective Case-Control Study.

Authors:  Roshan Acharya; Dilli Poudel; Riley Bowers; Aakash Patel; Evan Schultz; Michael Bourgeois; Rishi Paswan; Scott Stockholm; Macelyn Batten; Smita Kafle; Kriti Lonial; Irlene Locklear
Journal:  J Clin Med Res       Date:  2021-05-25

6.  LysoPC and PAF Trigger Arachidonic Acid Release by Divergent Signaling Mechanisms in Monocytes.

Authors:  Janne Oestvang; Marit W Anthonsen; Berit Johansen
Journal:  J Lipids       Date:  2011-09-11

7.  Fibrinogen Albumin Ratio and Ischemic Stroke During Venoarterial Extracorporeal Membrane Oxygenation.

Authors:  Prakash Acharya; William A Jakobleff; Stephen J Forest; Thiru Chinnadurai; Nicolas Mellas; Snehal R Patel; Jorge R Kizer; Henny H Billett; Daniel J Goldstein; Ulrich P Jorde; Omar Saeed
Journal:  ASAIO J       Date:  2020-03       Impact factor: 3.826

8.  Anticoagulant action of low, physiologic, and high albumin levels in whole blood.

Authors:  Margret Paar; Christine Rossmann; Christoph Nusshold; Thomas Wagner; Axel Schlagenhauf; Bettina Leschnik; Karl Oettl; Martin Koestenberger; Gerhard Cvirn; Seth Hallström
Journal:  PLoS One       Date:  2017-08-11       Impact factor: 3.240

9.  Serum Albumin Levels and Clinical Outcomes Among Ischemic Stroke Patients Treated with Endovascular Thrombectomy.

Authors:  Jie Gao; Ying Zhao; Mingyang Du; Hongquan Guo; Ting Wan; Min Wu; Ling Liu; Huaiming Wang; Qin Yin; Xinfeng Liu
Journal:  Neuropsychiatr Dis Treat       Date:  2021-02-10       Impact factor: 2.570

10.  Platelet activating factor stimulates arachidonic acid release in differentiated keratinocytes via arachidonyl non-selective phospholipase A2.

Authors:  Katarina Mariann Jørgensen; Hanne Solvang Felberg; Rolf K Berge; Astrid Laegreid; Berit Johansen
Journal:  Arch Dermatol Res       Date:  2009-12-30       Impact factor: 3.017

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.